Doceree, a Parsippany, N.J-based global network of physician-only platforms for programmatic messaging, raised $35 million in Series B funding.
The round was led by Creaegis, with participation from existing investors, Eight Roads Ventures, and F-Prime Capital.
Creaegis is a growth investment firm focused on digital and technology businesses with a team history of investing in some of the digital pioneers in India and the US. The firm targets a diversified range of sectors including consumer discretionary, financial service, information technology, and healthcare.
Doceree Use of Funds
The company will use the funds to accelerate product and technology development and support expansion efforts to reshape communications to HCPs (healthcare professionals) across the globe.
Founded in 2019, Doceree is a global platform building unique solutions for healthcare professional (HCP) programmatic messaging with proprietary data tools. Doceree provides solutions that enable pharmaceutical and life sciences companies, as well as healthcare media agencies, to reach HCPs within their digital workflows, ultimately aiming to improve patient health outcomes. It facilitates messaging between life sciences brands and HCPs through an extensive global network of digital endemic and point-of-care platforms to programmatically deliver personalized communications to HCPs at scale.
Company: Doceree, Inc.
Round: Series B
Funding Month: September 2023
Lead Investors: Creaegis
Additional Investors: Eight Roads Ventures, and F-Prime Capital
Company Website: https://doceree.com/
Software Category: AI-based Programmatic Marketing Platform